Coenzyme Q10 supplementation in the management of statin‐associated myalgia

@article{Tan2017CoenzymeQS,
  title={Coenzyme Q10 supplementation in the management of statin‐associated myalgia},
  author={Jason Eng Thye Tan and Arden R. Barry},
  journal={American Journal of Health-System Pharmacy},
  year={2017},
  volume={74},
  pages={786,788,790–791,793}
}
  • Jason Eng Thye Tan, Arden R. Barry
  • Published 2017
  • Medicine
  • American Journal of Health-System Pharmacy
  • Statins are indicated for use as first-line therapy in the prevention of major adverse cardiovascular events (e.g., myocardial infarction, stroke) in patients with or at risk for cardiovascular disease.[1][1] However, muscle-related adverse effects, including myopathy, often limit the use of statins 

    Topics from this paper.

    Citations

    Publications citing this paper.
    SHOWING 1-3 OF 3 CITATIONS

    Coenzyme Q10 for statin-associated myalgia.

    Do PCSK9 inhibitors reduce cardiovascular events?

    Prevention and management of statin adverse effects: A practical approach for pharmacists

    VIEW 1 EXCERPT
    CITES RESULTS

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 28 REFERENCES

    Effect of coenzyme Q(10) supplementation on simvastatin-induced myalgia.

    VIEW 3 EXCERPTS
    HIGHLY INFLUENTIAL

    Coenzyme Q(10) and selenium in statin-associated myopathy treatment.

    VIEW 2 EXCERPTS

    The role of coenzyme Q10 in statin-associated myopathy: a systematic review.

    VIEW 6 EXCERPTS
    HIGHLY INFLUENTIAL

    Coenzyme Q10 Supplementation Decreases Statin-Related Mild-to-Moderate Muscle Symptoms: A Randomized Clinical Study

    VIEW 2 EXCERPTS